Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-29 Sale |
2024-01-30 4:01 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
1,849 | $5 | $9,245 | 103,926 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 4:30 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
10,874 | $4.37 | $47,519 | 142,361 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 4:30 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
11,271 | $4.38 | $49,367 | 158,069 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 4:29 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
14,391 | $4.37 | $62,889 | 371,248 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 4:29 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
7,028 | $4.37 | $30,712 | 105,775 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-03 4:03 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
5,182 | $3.66 | $18,966 | 112,803 (Direct) |
View |
| 2023-12-26 Purchase |
2023-12-28 9:30 pm |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
44,630 | $3.72 | $166,024 | 16,491,128 (Indirect) |
View |
| 2023-12-18 Sale |
2023-12-19 4:01 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
1,585 | $3.5 | $5,548 | 117,985 (Direct) |
View |
| 2023-11-09 Sale |
2023-11-13 4:01 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
24,363 | $2.4 | $58,471 | 153,235 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-21 4:02 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
4,718 | $2.8 | $13,210 | 119,570 (Direct) |
View |
| 2023-08-04 Sale |
2023-08-07 4:01 pm |
FATE THERAPEUTICS INC | FATE | Xu Yuan Director |
632 | $3.71 | $2,345 | 9,302 (Direct) |
View |
| 2023-07-05 Sale |
2023-07-06 5:19 pm |
FATE THERAPEUTICS INC | FATE | Powl Brian T. Chief Commercial Officer |
3,854 | $4.87 | $18,769 | 41,146 (Direct) |
View |
| 2023-07-05 Sale |
2023-07-06 5:18 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
5,182 | $4.83 | $25,029 | 124,288 (Direct) |
View |
| 2023-06-14 Sale |
2023-06-15 4:05 pm |
FATE THERAPEUTICS INC | FATE | Xu Yuan Director |
3,460 | $5.58 | $19,307 | 9,934 (Direct) |
View |
| 2023-04-20 Purchase |
2023-04-21 9:55 pm |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
276,639 | $6.1663 | $1,705,829 | 13,135,758 (Indirect) |
View |
| 2023-04-18 Sale |
2023-04-19 4:07 pm |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Chief Medical Officer |
2,532 | $6.5749 | $16,648 | 140,676 (Direct) |
View |
| 2023-04-14 Purchase |
2023-04-17 9:30 pm |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
25,700 | $6 | $154,200 | 33,760,033 (Indirect) |
View |
| 2023-04-14 Sale |
2023-04-17 9:30 pm |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
302,339 | $5.84 | $1,765,660 | 33,760,033 (Indirect) |
View |
| 2023-01-11 Purchase |
2023-01-13 6:20 pm |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
124,679 | $5.5995 | $698,138 | 282,770 (Direct) |
View |
| 2023-01-10 Sale |
2023-01-11 4:09 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
45,907 | $5.24 | $240,553 | 385,639 (Direct) |
View |
| 2023-01-10 Sale |
2023-01-11 4:08 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
10,917 | $5.24 | $57,205 | 168,917 (Direct) |
View |
| 2023-01-10 Sale |
2023-01-11 4:08 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
11,553 | $5.24 | $60,538 | 177,598 (Direct) |
View |
| 2023-01-10 Sale |
2023-01-11 4:07 pm |
FATE THERAPEUTICS INC | FATE | Plavsic Mark Chief Technical Officer |
3,418 | $5.24 | $17,910 | 123,705 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-26 Other |
2023-12-28 9:30 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
1,655,370 | $3.72 | 16,491,128 (Indirect) |
View |
| 2023-06-06 Option Award |
2023-06-08 7:22 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2023-06-06 Option Award |
2023-06-08 7:22 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | Lee Michael Stewart Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:15 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | Xu Yuan Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:13 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | RASTETTER WILLIAM H Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:11 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:10 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | Jooss Karin Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:09 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:08 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | EPSTEIN ROBERT S Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:06 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | COUGHLIN TIMOTHY Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:05 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-04-14 Other |
2023-04-17 9:30 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
109,920 | $5.839 | 33,760,033 (Indirect) |
View |
| 2023-04-14 Other |
2023-04-17 9:30 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
6,592,385 | $5.84 | 33,760,033 (Indirect) |
View |
| 2023-04-13 Conversion |
2023-04-17 9:30 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
200,646 | $0 | 33,760,033 (Indirect) |
View |
| 2023-04-14 Other |
2023-04-17 9:30 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
91,504 | $29.2 | 33,760,033 (Indirect) |
View |
| 2023-02-06 Option Award |
2023-02-07 4:21 pm |
N/A 2033-02-05 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-07 4:20 pm |
N/A 2033-02-05 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
450,000 | $0 | 450,000 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-07 4:18 pm |
N/A 2033-02-05 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
425,000 | $0 | 425,000 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-07 4:16 pm |
N/A 2033-02-05 |
FATE THERAPEUTICS INC | FATE | Powl Brian T. Chief Commercial Officer |
425,000 | $0 | 425,000 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-07 4:15 pm |
N/A 2033-02-05 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
425,000 | $0 | 425,000 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-07 4:13 pm |
N/A 2033-02-05 |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Chief Medical Officer |
425,000 | $0 | 425,000 (Direct) |
View |
| 2023-01-19 Exercise |
2023-01-20 4:14 pm |
N/A 2023-02-06 |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
28,461 | $0 | 311,231 (Direct) |
View |
| 2023-01-19 Exercise |
2023-01-20 4:14 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
28,461 | $1.37 | 311,231 (Direct) |
View |
| 2023-01-12 Exercise |
2023-01-13 4:02 pm |
N/A 2023-01-14 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
423 | $0 | 169,340 (Direct) |
View |
| 2023-01-12 Exercise |
2023-01-13 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
423 | $1.37 | 169,340 (Direct) |
View |